6月17日 - ** Biomea Fusion公司BMEA.O股价在延时交易中下跌25%至2.10美元，该公司正在寻求股票融资
** 处于临床阶段的糖尿病和肥胖症药物开发商宣布 (link) 发行股票和认股权证；未披露目标融资额
** 杰富瑞（Jefferies）是拟议发行的唯一簿记管理人
** BMEA公司股票周二收盘上涨10.3%，报收于2.90美元，本月股价上涨约一倍
** 根据最新的美国证券交易委员会文件 (link)，截至 4 月 29 日，总部位于加利福尼亚州红木城的 BMEA 拥有约 3760 万股流通股，市值近 1.1 亿美元。
** LSEG的数据显示，在9位覆盖BMEA的分析师中，7位建议 "强烈买入 "或 "买入"，2位建议 "持有"，PT中值为17美元。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.